Chapter 13.4

Semaglutide vs Tirzepatide

The definitive battle of GLP-1 heavyweight agonists. Analyzing Mono-agonist vs Dual-agonist metabolic paths.

Weight Loss

GLP-1

GIP

Metabolic Intelligence

Attribute

Semaglutide

GLP-1 Agonist (Ozempic)

Tirzepatide

Dual GIP/GLP-1 Agonist

Key Benefits

Semaglutide

Significant Weight Loss
Glycemic Control
Cardiovascular Protection

Tirzepatide

Superior Weight Loss to GLP-1 Alone
Metabolic Flexibility
Lipid Profile Improvement

Common Side Effects

Nausea & Vomiting
Delayed Gastric Emptying
Reflux / Gastroparesis Risk

Gastrointestinal Distress
Decreased Appetite (Extreme)
Fatigue

Research Citations

Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) (2021)

Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) (2022)

Semaglutide Alpha

-14.9%Avg Weight Delta (68w)

Cardiac Shield

Proven 20% reduction in MACE (Major Cardiac Events)

Mono-Mechanism

Pure GLP-1 receptor agonism; long-term safety profile

Glycemic Control

Consistent -1.8% reduction in HbA1c for diabetics

Tirzepatide X

-22.5%High-Dose Delta (72w)

Dual Agonism

Synergistic GLP-1 + GIP receptor activation

Superior Delta

Significantly outperforms Semaglutide in weight loss

Metabolic Range

Dramatically improves insulin sensitivity cuerpo-wide

Which One is Right for You?

Choose Semaglutide If:

→You have cardiovascular disease (proven 20% risk reduction)
→You want longer track record (approved since 2017)
→You're sensitive to nausea (can micro-dose 0.125mg)
→Lower cost (compounded: $200-300/month)

Choose Tirzepatide If:

→You want MAXIMUM weight loss (20%+ body weight)
→You're diabetic (superior HbA1c reduction vs Sema)
→Less nausea than Semaglutide (anecdotal + trial data)
→Budget allows (compounded: $350-400/month)

Critical Clinical Warning

Muscle Loss Risk (Sarcopenia)

Phase 3 trials show up to 40% of weight lost on GLP-1 agonists can be skeletal muscle if protein intake and load-bearing exercise are not rigorously titrated. This creates metabolic damage and "Ozempic Face".

Protein Titration (1.5g/kg)

Resistance Training (3x/wk)

DEXA Monitoring

Secretagogue Stacking

Expert Consensus

"Weight loss without muscle preservation is a pyrrhic victory. We see accelerated sarcopenia in patients who ignore resistance training on GLP-1s."
— DR. PETER ATTIA

🔗 Related Tools

Previous: Semax vs Selank

← Chapter 13.3

Next: Ipamorelin vs GHRP

Chapter 13.5 →

Metabolic Hub

GLP-1 Central

Loading dashboard...

Which One is Right for You?

Choose Semaglutide If:

→You have cardiovascular disease (proven 20% risk reduction)
→You want longer track record (approved since 2017)
→You're sensitive to nausea (can micro-dose 0.125mg)
→Lower cost (compounded: $200-300/month)

Choose Tirzepatide If:

→You want MAXIMUM weight loss (20%+ body weight)
→You're diabetic (superior HbA1c reduction vs Sema)
→Less nausea than Semaglutide (anecdotal + trial data)
→Budget allows (compounded: $350-400/month)

Peptide Assistant

Command Center
BETA

Learning Journey

Semaglutide vs Tirzepatide

Key Benefits

Common Side Effects

Research Citations

Semaglutide Alpha

Tirzepatide X

Which One is Right for You?

Choose Semaglutide If:

Choose Tirzepatide If:

Muscle Loss Risk (Sarcopenia)

Expert Consensus

🔗 Related Tools

Semaglutide vs Tirzepatide

Key Benefits

Common Side Effects

Research Citations

Semaglutide Alpha

Tirzepatide X

Which One is Right for You?

Choose Semaglutide If:

Choose Tirzepatide If:

Muscle Loss Risk (Sarcopenia)

Expert Consensus

🔗 Related Tools

Peptide Assistant

Command Center BETA

Learning Journey

Key Benefits

Common Side Effects

Research Citations

Semaglutide Alpha

Tirzepatide X

Which One is Right for You?

Choose Semaglutide If:

Choose Tirzepatide If:

Muscle Loss Risk (Sarcopenia)

Expert Consensus

🔗 Related Tools

Key Benefits

Common Side Effects

Research Citations

Semaglutide Alpha

Tirzepatide X

Which One is Right for You?

Choose Semaglutide If:

Choose Tirzepatide If:

Muscle Loss Risk (Sarcopenia)

Expert Consensus

🔗 Related Tools

Command Center
BETA